Unexpected Toxicity of Combination Thalidomide and Interferon Alfa-2a Treatment in Metastatic Renal Cell Carcinoma
- 1 March 2002
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (5) , 1429-1430
- https://doi.org/10.1200/jco.2002.20.5.1429
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The treatment of advanced renal cell cancer with high-dose oral thalidomideBritish Journal of Cancer, 2001
- Thalidomide in CancerBioDrugs, 2001
- Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancerBritish Journal of Cancer, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999